It’s a Matter of Choice: Hybrid eConsent for On-Site or Remote Patient Enrollment
Thought leaders from Castor and Lightship discuss opportunities that will help researchers develop a more successful overall strategy for their patient enrollment.
Download this eBook to gain a comprehensive overview of eConsent, how it satisfies global regulatory requirements and key considerations for ethics board approval.
3 Ways eConsent Tackles the Challenges of Modern Clinical Trials
Although eConsent struggled to gain momentum and wider acceptance pre-pandemic, it’s now a major part of clinical research. In this article, learn three ways eConsent addresses the requirements for valid informed consent.
Trialbee and Castor Partner to Democratize Access and Simplify Enrollment to Clinical Trials Globally
Trialbee, the leading enrollment performance company, and Castor, a leading provider of decentralized and hybrid clinical trial solutions, today announced a strategic partnership to accelerate patient enrollment, optimize patient engagement, and reduce site burden for clinical trials globally.
Castor Expands Executive Leadership Team to Scale Clinical Trial Platform Technology
announced two executive appointments to accelerate the company’s growth and impact on the industry. Kimberly Tableman as Chief Clinical Development Officer (CCDO) and Anna Wozniak as Chief Financial & Development Officer (CFDO).
The evolution of eConsent
Since it was first instituted in the 1960s, written consent to participate in research studies has undergone very little change other than tightening regulations and increased participant education of their rights.
What is eConsent?
eConsent accelerates enrollment, increases retention, and reduces site burden. Find out why it’s the way of the future for clinical trials here.
Case Study: COVID-RED Uses Castor’s Decentralized eClinical Platform
Download this case study to learn how Castor responded to the disruptive impact of COVID-19 and helped the COVID-RED study implement decentralized clinical trial methods to recruit over 17,825 participants in just 15 weeks.
Castor Leads Next-Gen Clinical Trials that Support Digital Therapeutics
Castor’s new eConsent platform will improve remote patient recruitment and enrollment as well as access to diverse populations by decentralizing clinical trials.